首页> 美国卫生研究院文献>Hepatitis Monthly >Efficacy of Hepatoprotective Agents With or Without Antiviral Drugs on Liver Function and Fibrosis in Patients With Hepatitis B: A Meta-Analysis

【2h】

Efficacy of Hepatoprotective Agents With or Without Antiviral Drugs on Liver Function and Fibrosis in Patients With Hepatitis B: A Meta-Analysis

机译：有或没有抗病毒药物的肝保护剂对乙型肝炎患者肝功能和纤维化的疗效：一项荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Context:To systematically evaluate the effects of hepatoprotective agents, when delivered either alone or in combination with other antiviral or non-antiviral drugs in patients with hepatitis B and hepatic fibrosis.

机译：背景：系统评估肝保护剂单独或与其他抗病毒药或非抗病毒药联用对乙型肝炎和肝纤维化患者的作用。

著录项

期刊名称 Hepatitis Monthly
作者
Li-Hui Long; Cai-Qin Xue; Jun-Feng Shi; Juan-Ni Dong; Li Wang;
展开▼
作者单位

展开▼
年(卷),期 2015(15),7
年度 2015
页码 e29052
总页数 12
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Hepatitis B Liver Cirrhosis Meta-Analysis Ursodeoxycholic Acid (UDCA) Silibinin Acetylcysteine;

机译：乙型肝炎;肝硬化;Meta分析;熊去氧胆酸（UDCA）;水飞蓟宾;乙酰半胱氨酸;

相似文献

外文文献
中文文献
专利

1. EFFICACY OF HEPATOPROTECTIVE AGENTS WITH OR WITHOUT ANTIVIRAL DRUGS ON LIVER FUNCTION AND FIBROSIS IN PATIENTS WITH HEPATITIS B: A META-ANALYSIS [J] . LONG LI HUI, XUE CAI QIN, SHI JUN FENG, Hepatitis Monthly . 2015,第7期

机译：乙型肝炎患者有或无抗病毒药物对肝功能和纤维化的肝保护作用：荟萃分析
2. Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C [J] . Garcia-Pajares F., Tejedor-Tejada J., Torres-Yuste R., Transplantation Proceedings . 2019,第1期

机译：直接作用抗病毒改善丙型肝炎感染肝移植受者的临床病症，纤维化和肝功能的疗效
3. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis [J] . Petta Salvatore, Adinolfi Luigi Elio, Fracanzani Anna Ludovica, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2018,第1期

机译：通过直接作用抗病毒药物消除丙型肝炎病毒改善了严重肝纤维化患者的颈动脉粥样硬化
4. MALDI-TOF MS for Monitoring Drug Resistance in Hepatitis B Virus-Infected Patients during Antiviral Therapy [C] . Magda Rybicka, Piotr Stalke, Tomasz Smiatacz, International Mass Spectrometry Conference . 2014

机译：MALDI-TOF MS用于监测抗病毒治疗期间乙型肝炎病毒感染患者耐药性的MS
5. Analyzing the Impact of the CMS Guidance on Assuring Access to Hepatitis C Virus (HCV) Drugs on Utilization of Direct-Acting Antiviral (DAA) Agents [D] . Ferrell, Kelli Walker. 2017

机译：分析CMS指南对确保获得丙型肝炎病毒（HCV）药物对直接作用抗病毒（DAA）药物利用的影响
6. Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis [O] . Jingxuan Lian, Jianfang Fu 2021

机译：各种降血糖药物在治疗非酒精性肝病患者的疗效或没有糖尿病：网络荟萃分析
7. Efficacy of Hepatoprotective Agents With or Without Antiviral Drugs on Liver Function and Fibrosis in Patients With Hepatitis B: A Meta-Analysis [O] . Li-Hui Long, Cai-Qin Xue, Jun-Feng Shi, 2015

机译：HepatoPotective代理与抗病毒药物对乙型肝炎患者肝功能和纤维化的疗效：META分析

Efficacy of Hepatoprotective Agents With or Without Antiviral Drugs on Liver Function and Fibrosis in Patients With Hepatitis B: A Meta-Analysis

摘要

著录项

相似文献

相关主题

期刊订阅